Trial Outcomes & Findings for A Cluster-randomized Controlled Knowledge Translation Feasibility Study in Alberta Community Pharmacies (NCT NCT02191111)
NCT ID: NCT02191111
Last Updated: 2023-01-05
Results Overview
Difference in the number of billable services (influenza vaccinations, Comprehensive Annual Care Plans and follow-ups, and Standard Medication Management Assessments and follow-ups) between the intervention period and the 6-months prior to intervention (baseline)
COMPLETED
NA
10 participants
6 month intervention period vs. 6 month baseline prior to intervention
2023-01-05
Participant Flow
Unit of analysis: pharmacies
Participant milestones
| Measure |
Task-focused Facilitation
An external, task-focused facilitation, informed by an evaluation of contextual factors using the Alberta Context Tool (ACT), will be applied to train community pharmacies to develop alternative team processes that enable a greater number of medication management services to be provided to patients with diabetes, hypertension, and/or dyslipidemia.
Task-focused facilitation: An external, task-focused facilitation, informed by an evaluation of contextual factors using the Alberta Context Tool (ACT), will be applied to train community pharmacies to develop alternative team processes that enable a greater number of medication management services to be provided to patients with diabetes, hypertension, and/or dyslipidemia.
|
Control
These sites will continue practice as usual, with no contact from study staff.
|
|---|---|---|
|
Overall Study
STARTED
|
0 5
|
0 5
|
|
Overall Study
COMPLETED
|
0 5
|
0 5
|
|
Overall Study
NOT COMPLETED
|
0 0
|
0 0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
A Cluster-randomized Controlled Knowledge Translation Feasibility Study in Alberta Community Pharmacies
Baseline characteristics by cohort
| Measure |
Task-focused Facilitation
n=5 Pharmacies
An external, task-focused facilitation, informed by an evaluation of contextual factors using the Alberta Context Tool (ACT), will be applied to train community pharmacies to develop alternative team processes that enable a greater number of medication management services to be provided to patients with diabetes, hypertension, and/or dyslipidemia.
Task-focused facilitation: An external, task-focused facilitation, informed by an evaluation of contextual factors using the Alberta Context Tool (ACT), will be applied to train community pharmacies to develop alternative team processes that enable a greater number of medication management services to be provided to patients with diabetes, hypertension, and/or dyslipidemia.
|
Control
n=5 Pharmacies
These sites will continue practice as usual, with no contact from study staff.
|
Total
n=10 Pharmacies
Total of all reporting groups
|
|---|---|---|---|
|
Age, Customized
Pharmacies
|
0 Age data not collected
|
0 Age data not collected
|
0 Age data not collected
|
|
Sex/Gender, Customized
Pharmacies
|
0 Pharmacies
|
0 Pharmacies
|
0 Pharmacies
|
|
Alberta context tool, semi-structured interviews, medication management counts, close out interviews
|
2.86 units on a scale
|
3.14 units on a scale
|
3 units on a scale
|
PRIMARY outcome
Timeframe: 6 month intervention period vs. 6 month baseline prior to interventionPopulation: Units of measure were community pharmacies
Difference in the number of billable services (influenza vaccinations, Comprehensive Annual Care Plans and follow-ups, and Standard Medication Management Assessments and follow-ups) between the intervention period and the 6-months prior to intervention (baseline)
Outcome measures
| Measure |
Task-focused Facilitation
n=4557 Billable pharmacy services
An external, task-focused facilitation, informed by an evaluation of contextual factors using the Alberta Context Tool (ACT), will be applied to train community pharmacies to develop alternative team processes that enable a greater number of medication management services to be provided to patients with diabetes, hypertension, and/or dyslipidemia.
Task-focused facilitation: An external, task-focused facilitation, informed by an evaluation of contextual factors using the Alberta Context Tool (ACT), will be applied to train community pharmacies to develop alternative team processes that enable a greater number of medication management services to be provided to patients with diabetes, hypertension, and/or dyslipidemia.
|
Control
n=5886 Billable pharmacy services
These sites will continue practice as usual, with no contact from study staff.
|
|---|---|---|
|
Change in Service Counts From Baseline to End of Intervention Period
Influenza Vaccinations (Study Period)
|
3199 Billable pharmacy services
|
4140 Billable pharmacy services
|
|
Change in Service Counts From Baseline to End of Intervention Period
SMMA Follow-Up (Baseline)
|
67 Billable pharmacy services
|
105 Billable pharmacy services
|
|
Change in Service Counts From Baseline to End of Intervention Period
SMMA Follow-Up (Study Period)
|
41 Billable pharmacy services
|
88 Billable pharmacy services
|
|
Change in Service Counts From Baseline to End of Intervention Period
SMMA Diabetes (Baseline)
|
3 Billable pharmacy services
|
4 Billable pharmacy services
|
|
Change in Service Counts From Baseline to End of Intervention Period
SMMA Diabetes (Study Period)
|
1 Billable pharmacy services
|
1 Billable pharmacy services
|
|
Change in Service Counts From Baseline to End of Intervention Period
SMMA Diabetes Follow-Up (Baseline)
|
8 Billable pharmacy services
|
5 Billable pharmacy services
|
|
Change in Service Counts From Baseline to End of Intervention Period
SMMA Diabetes Follow-Up (Study Period)
|
4 Billable pharmacy services
|
5 Billable pharmacy services
|
|
Change in Service Counts From Baseline to End of Intervention Period
SMMA Tobacco (Baseline)
|
21 Billable pharmacy services
|
6 Billable pharmacy services
|
|
Change in Service Counts From Baseline to End of Intervention Period
SMMA Tobacco (Study Period)
|
8 Billable pharmacy services
|
12 Billable pharmacy services
|
|
Change in Service Counts From Baseline to End of Intervention Period
SMMA Tobacco Follow-Up (Baseline)
|
4 Billable pharmacy services
|
4 Billable pharmacy services
|
|
Change in Service Counts From Baseline to End of Intervention Period
SMMA Tobacco Follow-Up (Study Period)
|
5 Billable pharmacy services
|
6 Billable pharmacy services
|
|
Change in Service Counts From Baseline to End of Intervention Period
Influenza Vaccinations (Baseline)
|
406 Billable pharmacy services
|
2 Billable pharmacy services
|
|
Change in Service Counts From Baseline to End of Intervention Period
CACP (Baseline)
|
172 Billable pharmacy services
|
284 Billable pharmacy services
|
|
Change in Service Counts From Baseline to End of Intervention Period
CACP (Study Period)
|
121 Billable pharmacy services
|
166 Billable pharmacy services
|
|
Change in Service Counts From Baseline to End of Intervention Period
CACP Follow-Up (Baseline)
|
295 Billable pharmacy services
|
507 Billable pharmacy services
|
|
Change in Service Counts From Baseline to End of Intervention Period
CACP Follow-Up (Study Period)
|
106 Billable pharmacy services
|
372 Billable pharmacy services
|
|
Change in Service Counts From Baseline to End of Intervention Period
SMMA (Baseline)
|
50 Billable pharmacy services
|
115 Billable pharmacy services
|
|
Change in Service Counts From Baseline to End of Intervention Period
SMMA (Study Period)
|
46 Billable pharmacy services
|
64 Billable pharmacy services
|
Adverse Events
Task-focused Facilitation
Control
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place